Disc Medicine (IRON) Free Cash Flow (2020 - 2026)

Disc Medicine (IRON) has reported Free Cash Flow for 7 consecutive years, with -$44.2 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Free Cash Flow rose 7.83% year-over-year to -$44.2 million; the TTM figure through Jun 2026 stood at -$197.6 million (down 45.76% YoY), while the FY2025 annual figure was -$181.3 million, down 92.02% from the prior year.
• Free Cash Flow advanced to -$44.2 million in Q2 2026 per IRON's latest filing, from -$62.2 million in the prior quarter.
• Across five years, Free Cash Flow topped out at -$7.5 million in Q3 2023 and bottomed at -$62.2 million in Q1 2026.
• Historically, Free Cash Flow has averaged -$27.7 million across 5 years, with a median of -$22.9 million in 2023.
• Annual changes were most pronounced in 2022 — Free Cash Flow soared 42.15% — and 2025, when it plunged 211.59%.
• Disc Medicine's Free Cash Flow stood at -$9.7 million in 2022, then slumped by 83.93% to -$17.8 million in 2023, then slumped by 57.44% to -$28.0 million in 2024, then slumped by 54.59% to -$43.3 million in 2025, then fell by 2.03% to -$44.2 million in 2026.
• Business Quant data shows IRON's Free Cash Flow at -$44.2 million in Q2 2026, -$62.2 million in Q1 2026, and -$43.3 million in Q4 2025.